Aspira Women’s Health Reports Third Quarter 2022 Financial Results

November 10, 2022

https://www.globenewswire.com/news-release/2022/11/10/2552997/0/en/Aspira-Women-s-Health-Reports-Third-Quarter-2022-Financial-Results.html

Increased year-over-year product revenue by 26% to $2.0 million and year-over-year product volume by 29% to 5,524 units

Reconfirmed fourth quarter launch of OvaWatch ovarian cancer risk assessment and announced rebranding of the ovarian cancer product portfolio as OvaSuite

Read more at globenewswire.com

Related news for (AWH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.